Clinical Trials
205 trialsA Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab
University of Wisconsin, Madison
A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients
Mclean Hospital
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Inmune Bio, Inc.
Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
Exelixis
A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
National Institutes of Health Clinical Center (CC)
Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases
University of Pittsburgh
FIGHT-209
Incyte Corporation
Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
Shuttle Pharmaceuticals, Inc.
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
Yale University
NeoGlio
Geisinger Clinic
Pembro+Chemo in Brain Mets
University of Kentucky
PersoMed-I
European Organisation for Research and Treatment of Cancer - EORTC
JAZZ
Wake Forest University Health Sciences
Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
Day One Biopharmaceuticals, Inc.
Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
OHSU Knight Cancer Institute
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
National Institutes of Health Clinical Center (CC)
ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
Jazz Pharmaceuticals
Pembrolizumab And Lenvatinib In Leptomeningeal Metastases
Massachusetts General Hospital
STARBURST
Telix Pharmaceuticals (Innovations) Pty Limited
Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults
M.D. Anderson Cancer Center
ACT-FAST
AHS Cancer Control Alberta
VB-111 in Surgically Accessible Recurrent/Progressive GBM
Dana-Farber Cancer Institute
RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases
Biogen
OU-SCC-PI-4G
University of Oklahoma
SEL-TH-1601
Children's Hospital Medical Center, Cincinnati
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
Alaunos Therapeutics
STIR
Medical College of Wisconsin
NOA11
University Hospital Muenster
NORTH
Australian & New Zealand Children's Haematology/Oncology Group
A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma
Rabin Medical Center
Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
Alliance for Clinical Trials in Oncology
Oral ONC201 in Adult Recurrent Glioblastoma
Jazz Pharmaceuticals
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
Washington University School of Medicine
BRAF
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)
Beijing Sanbo Brain Hospital
Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
Wake Forest University Health Sciences
CA209-322
University Medical Center Groningen
UVA-Gen001
University of Virginia
NeAT Glio
University College, London
IORT
Xoft, Inc.
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
St. Joseph's Hospital and Medical Center, Phoenix
I-ATTAC
Duke University
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
Hoosier Cancer Research Network
Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
Jonsson Comprehensive Cancer Center
CLQ
Instituto Nacional de Cancerologia de Mexico
SynCoRAS
Technical University of Munich
RadioCoBRIM
Technische Universität Dresden
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
OHSU Knight Cancer Institute
ALpha-T
Hoffmann-La Roche
Focal Intraoperative Radiotherapy of Brain Metastases
AC Camargo Cancer Center